second fiscal quarter 2027
Filed Sep 3, 2026Docusign Announces Second Quarter Fiscal 2027 Financial Results; Company Increases Fiscal Year 2027 Guidance for Revenue, ARR and IAM’s Percentage of Total ARR
Revenue grew 9% year over year, GAAP and non-GAAP operating margins improved, free cash flow increased to $295,757, and the company increased fiscal year 2027 guidance for revenue, ARR and IAM’s percentage of total ARR.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| RevenueGAAP | $ 875,746 | – | 9% |
| Gross profitGAAP | $ 697,874 | – | – |
| Gross marginGAAP | 79.7 % | – | – |
| Gross profitnon-GAAP | $ 715,514 | – | – |
| Gross marginnon-GAAP | 81.7 % | – | – |
| Sales and marketing expenseGAAP | $ 313,958 | – | – |
| Sales and marketing as a percentage of revenueGAAP | 35.9 % | – | – |
| Sales and marketing expensenon-GAAP | $ 261,663 | – | – |
| Sales and marketing as a percentage of revenuenon-GAAP | 29.9 % | – | – |
| Research and development expenseGAAP | $ 163,582 | – | – |
| Research and development as a percentage of revenueGAAP | 18.7 % | – | – |
| Research and development expensenon-GAAP | $ 105,949 | – | – |
| Research and development as a percentage of revenuenon-GAAP | 12.1 % | – | – |
| General and administrative expenseGAAP | $ 102,713 | – | – |
| General and administrative as a percentage of revenueGAAP | 11.7 % | – | – |
| General and administrative expensenon-GAAP | $ 71,126 | – | – |
| General and administrative as a percentage of revenuenon-GAAP | 8.1 % | – | – |
| Total operating expensesGAAP | $ 580,253 | – | – |
| Income from operationsGAAP | $ 117,621 | – | – |
| Operating marginGAAP | 13.4 % | – | – |
| Income from operationsnon-GAAP | $ 276,776 | – | – |
| Operating marginnon-GAAP | 31.6 % | – | – |
| Income before provision for income taxesGAAP | $ 124,976 | – | – |
| Provision for income taxesGAAP | $ 47,261 | – | – |
| Net incomeGAAP | $ 77,715 | – | – |
| Net income attributable to common stockholdersnon-GAAP | $ 224,463 | – | – |
| Net income per share, basicGAAP | $ 0.41 | – | – |
| Net income per share, dilutedGAAP | $ 0.40 | – | – |
| Net income per share, basicnon-GAAP | $ 1.17 | – | – |
| Net income per share, dilutednon-GAAP | $ 1.16 | – | – |
| Weighted-average common shares outstanding, basicGAAP | 191,252 | – | – |
| Weighted-average common shares outstanding, dilutedGAAP | 193,117 | – | – |
| Net cash provided by operating activitiesGAAP | $ 334,546 | – | – |
| Free cash flownon-GAAP | $ 295,757 | – | – |
| Free cash flow marginnon-GAAP | 34 % | – | – |
| IAM as a percentage of total ARRother | 15.1% | – | – |
| Six-month revenueGAAP | $ 1,705,981 | – | – |
| Six-month net incomeGAAP | $ 155,912 | – | – |
| Six-month net cash provided by operating activitiesGAAP | $ 656,234 | – | – |
| Six-month free cash flownon-GAAP | $ 585,192 | – | – |
Three Months Ended October 31, 2026 and Year Ended January 31, 2027 outlook
- RevenueThree Months Ended October 31, 2026: $886 to $890; Year Ended January 31, 2027: $3,499 to $3,507
- Gross marginThree Months Ended October 31, 2026: 81.5% to 81.9%; Year Ended January 31, 2027: 81.5% to 82.0%
- NoteThree Months Ended October 31, 2026 non-GAAP operating margin: 31.3% to 31.7%
- NoteThree Months Ended October 31, 2026 non-GAAP diluted weighted-average shares outstanding: 191 to 196
- NoteYear Ended January 31, 2027 annual recurring revenue year-over-year growth rate: 8.50% to 9.00%
- NoteYear Ended January 31, 2027 non-GAAP operating margin: 31.0% to 31.5%
- NoteYear Ended January 31, 2027 non-GAAP diluted weighted-average shares outstanding: 190 to 195
- NoteIAM will represent approximately 18% to 19% of total ARR exiting Q4 of Fiscal 2027.
- NoteExcluding the impact of foreign currency exchange rates on year-over-year guided revenue growth, revenue guidance range would be approximately 1.0% points lower for the quarter ending October 31, 2026 and 1.2% points lower for the fiscal year ending January 31, 2027.
Capital returns
- Repurchases of common stock were $306.5 million, compared to $201.5 million in the same period last year.
- Repurchases of common stock were $ 306,516, compared to $ 201,514 in the same period last year.
- Six-month repurchases of common stock were $ 624,026, compared to $ 384,945 in the same period last year.
What drove it
- Revenue increased 9% year over year, including a benefit of approximately 1.3% from the impact of foreign exchange rates.
- IAM represented 15.1% of total ARR as of July 31, 2026, compared to 12.6% as of April 30, 2026.
- The company launched agentic tools powered by Iris, including an AI assistant, pre-built agents, Agent Studio, and the ability to add agents directly into Workflow Builder.
- Docusign released its Model Context Protocol server and expanded integrations with Slack, Perplexity, and Google Cloud’s Gemini Enterprise for Legal solution.
- Docusign integrated IAM capabilities including Agreement Manager into Docusign CLM.
Concerns
- Non-GAAP gross margin was 81.7%, compared to 82.0% in the same period last year.
- The fiscal year 2027 annual recurring revenue year-over-year growth rate guidance range is 8.50% to 9.00%.
- GAAP general and administrative expense was $ 102,713, compared to $ 94,866 in the same period last year.
- The company cited uncertainty regarding customer renewals, sales force and go-to-market changes, cloud migration, AI deployment, macroeconomic conditions, foreign exchange rates, competition, and cybersecurity risks in its forward-looking statements.
What to watch
- Execution toward IAM representing approximately 18% to 19% of total ARR exiting Q4 of Fiscal 2027.
- Revenue guidance of $886 to $890 for the three months ended October 31, 2026 and $3,499 to $3,507 for the year ended January 31, 2027.
- Annual recurring revenue year-over-year growth rate guidance of 8.50% to 9.00% for the year ended January 31, 2027.
- Whether non-GAAP gross margin remains within the guided ranges of 81.5% to 81.9% for the October quarter and 81.5% to 82.0% for fiscal 2027.
- The pace of common-stock repurchases following $ 306,516 during the quarter.
Balance sheet and cash flow
- Cash, cash equivalents, and investments were $973.1 million at the end of the quarter.
- Cash and cash equivalents were $ 528,161 at July 31, 2026, compared to $ 602,442 at January 31, 2026.
- Investments—current were $ 249,516 at July 31, 2026, compared to $ 264,084 at January 31, 2026.
- Investments—noncurrent were $ 195,398 at July 31, 2026, compared to $ 208,393 at January 31, 2026.
- Purchases of property and equipment were $ 38,789, compared to $ 28,425 in the same period last year.
- Net cash used in investing activities was $ 6,878, compared to $ 30,452 in the same period last year.
- Net cash used in financing activities was $ 345,096, compared to $ 273,340 in the same period last year.
- Net decrease in cash, cash equivalents and restricted cash was $ 20,195, compared to $ 56,190 in the same period last year.
- Total assets were $ 3,960,790 at July 31, 2026, compared to $ 4,229,550 at January 31, 2026.
- Total liabilities were $ 2,242,270 at July 31, 2026, compared to $ 2,311,730 at January 31, 2026.
- Total stockholders’ equity was $ 1,718,520 at July 31, 2026, compared to $ 1,917,820 at January 31, 2026.
Analysis
Docusign reported second fiscal quarter revenue of $ 875,746, compared with $ 800,636 in the same period last year, and characterized the increase as 9% year over year. The company said foreign exchange rates provided a benefit of approximately 1.3% to revenue growth. IAM represented 15.1% of total ARR as of July 31, 2026, up from 12.6% as of April 30, 2026, showing greater IAM penetration within the ARR base.
Profitability improved materially on a GAAP operating basis. GAAP income from operations was $ 117,621, compared with $ 65,227, and GAAP operating margin was 13.4 %, compared with 8.1 %. Non-GAAP income from operations was $ 276,776, compared with $ 238,729, while non-GAAP operating margin increased to 31.6 % from 29.8 %. GAAP gross margin increased to 79.7 % from 79.3 %, although non-GAAP gross margin declined to 81.7 % from 82.0 %.
Expense mix was favorable in sales and marketing and research and development as a percentage of revenue. GAAP sales and marketing as a percentage of revenue declined to 35.9 % from 38.2 %, and GAAP research and development as a percentage of revenue declined to 18.7 % from 21.2 %. GAAP general and administrative expense increased to $ 102,713 from $ 94,866, while its percentage of revenue was 11.7 %, compared with 11.8 %. GAAP net income was $ 77,715 versus $ 62,970, and diluted GAAP net income per share was $ 0.40 versus $ 0.30. Diluted non-GAAP net income per share was $ 1.16 versus $ 0.92.
Cash generation strengthened. Net cash provided by operating activities was $ 334,546, compared with $ 246,073, and free cash flow was $ 295,757, compared with $ 217,648. Free cash flow margin reached 34 %, versus 27 %. The company repurchased $ 306,516 of common stock during the quarter, compared with $ 201,514 in the prior-year period, while cash, cash equivalents, and investments were $973.1 million at quarter end.
The company increased fiscal year 2027 guidance for revenue, ARR and IAM’s percentage of total ARR. It expects revenue of $886 to $890 for the three months ending October 31, 2026 and $3,499 to $3,507 for the year ending January 31, 2027. It guided fiscal-year ARR growth of 8.50% to 9.00%, expects IAM to represent approximately 18% to 19% of total ARR exiting Q4 of Fiscal 2027, and guided fiscal-year non-GAAP operating margin of 31.0% to 31.5%.
Management, verbatim
Docusign is raising its outlook as AI accelerates momentum across the business.
Allan Thygesen, CEO of Docusign
We said IAM would be the agreement system of action, and this quarter we delivered. Our AI agents are now securely executing contract workflows end-to-end, and the IAM platform also ingested a record volume of agreements.
Allan Thygesen, CEO of Docusign
Not in the filing
stated, not guessed- Prior outlook was not provided, so comparison of actual results with prior guidance is unavailable.
- Segment revenue, segment profitability, and segment growth metrics were not reported.
- Total ARR amount was not reported.
- Prior-quarter revenue, income, margin, EPS, operating cash flow, and free cash flow comparisons were not reported.
- Debt or borrowings outstanding were not reported.
- Dividend information was not reported.
- GAAP forward guidance for gross margin, operating margin, operating expenses, tax rate, net income, EPS, operating cash flow, or free cash flow was not provided.
- Forward free cash flow guidance was not provided.
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.